Fly News Breaks for March 2, 2015
ISIS
Mar 2, 2015 | 08:22 EDT
As noted earlier, Stifel downgraded Isis to Hold from Buy. As reasons for the downgrade, the firm cited the 3-4 year delay of the company's ISIS-ApoC3 drug and a lack of near-term, easily attainable catalysts.
News For ISIS From the Last 2 Days
There are no results for your query ISIS